New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer.
作者信息
Lin Ching-Yu, Chuu Chih-Pin
机构信息
Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Miaoli.
PhD Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University, Taipei.
出版信息
Transl Androl Urol. 2020 Apr;9(2):837-839. doi: 10.21037/tau.2020.03.24.
Abstract
摘要
Zotero 插件